CHMP5 and COVID-19: The spike protein has been directly related to both the pathophysiology that underlies COVID-19 viral illness and the serious adverse events from the COVID-19 vaccines that, via gene therapy mechanisms, induce human cells to produce the spike protein in substantial numbers.